Methylamine

Methylamine

SCHEMBL16611546

CCCCCCCCCCCCCCCCCCOS(=O)(=O)OCCCCCCCCCCCCCCCCCC.CN

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 16/20 0.68
CA2 P00918 16/20 0.68
CA9 Q16790 14/20 0.68
CA12 O43570 5/20 0.68
CA7 P43166 5/20 0.68
CA14 Q9ULX7 5/20 0.68
CA3 P07451 4/20 0.68
CA4 P22748 4/20 0.68
CA6 P23280 4/20 0.68
CA5A P35218 4/20 0.68
CA5B Q9Y2D0 4/20 0.68
RECQL P46063 2/20 0.59
TSHR P16473 2/20 0.59
GLA P06280 1/20 0.59
HPGD P15428 1/20 0.59
MAPK1 P28482 1/20 0.59
EPHX2 P34913 1/20 0.59
BLM P54132 1/20 0.59
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148280 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL5199618 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL3354 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL474049 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL771183 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL2494632 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL147679 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL41458 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL143596 0.95 CA1 (0.67) CA1CA2CA9CA12CA7
SCHEMBL42396 0.95 CA1 (0.67) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3279300-B1 FRAGRANCE COMPOSITION KAO CORP (JP) 2019-03-27 EP disclosed
EP-3279300-A1 FRAGRANCE COMPOSITION KAO CORPORATION (JP) 2018-02-07 EP disclosed
EP-2857482-B1 PERFUME COMPOSITION KAO CORP (JP) 2017-10-11 EP disclosed
US-9567550-B2 Fragrance composition KAO CORPORATION (JP) 2017-02-14 US disclosed
US-20160376521-A1 PERFUME COMPOSITION KAO CORPORATION (JP) 2016-12-29 US disclosed
US-20160326457-A1 ESTER KAO CORPORATION (JP) 2016-11-10 US disclosed
EP-3075822-A1 PERFUME COMPOSITION Kao Corporation (JP) 2016-10-05 EP disclosed
EP-3072877-A1 ESTER Kao Corporation (JP) 2016-09-28 EP disclosed
US-20150118174-A1 FRAGRANCE COMPOSITION KAO CORPORATION (JP) 2015-04-30 US disclosed
EP-2857482-A1 PERFUME COMPOSITION Kao Corporation (JP) 2015-04-08 EP disclosed
CN-101160278-B Method for the production of 1,3,5-trifluoro-2,4,6-trichlorobenzene from fluorobenzene derivatives BASF AG 2011-02-09 CN disclosed
CN-101160278-A Method for the production of 1,3,5-trifluoro-2,4,6-trichlorobenzene from fluorobenzene derivatives BASF AG (DE) 2008-04-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150118174-A1 FRAGRANCE COMPOSITION FAAH2, FAAH, DACH1 CA1 949/4885CA2 1779/4885CA9 973/4885
US-20160376521-A1 PERFUME COMPOSITION DEGS1, ALG3, DHCR24 CA1 1862/4885CA2 2231/4885CA9 1925/4885
US-20160326457-A1 ESTER MEP1A, ELOVL1, EBP CA1 3677/4885CA2 4395/4885CA9 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.